Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Sponsor: GOG Foundation
A PHASE3 clinical study on Cervical Adenocarcinoma and Cervical Adenosquamous Carcinoma, this trial is completed. The trial is conducted by GOG Foundation and has accumulated 15 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Jun 2025 — Sep 2025 [monthly]
Completed PHASE3
Status: Unknown → Completed
-
Sep 2024 — Jun 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
▶ Show 10 earlier versions
-
Jun 2022 — Jun 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Nov 2021 — Jun 2022 [monthly]
Recruiting PHASE3
-
Feb 2021 — Nov 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Apr 2019 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE3
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Jun 2017 — Sep 2017 [monthly]
Recruiting PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GOG Foundation
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .